Literature DB >> 16847278

Not-so-surprising findings.

Sebastian Schneeweiss, Daniel H Solomon.   

Abstract

Mesh：

Year:  2006        PMID： 16847278      PMCID： PMC1489992          DOI： 10.1503/cmaj.1060090

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.

Authors:  Wayne A Ray; C Michael Stein; James R Daugherty; Kathi Hall; Patrick G Arbogast; Marie R Griffin
Journal:  Lancet       Date:  2002-10-05       Impact factor: 79.321

Review 2.  Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat.

Authors:  Alexandra Barratt; Peter C Wyer; Rose Hatala; Thomas McGinn; Antonio L Dans; Sheri Keitz; Virginia Moyer; Gordon Guyatt For
Journal:  CMAJ       Date:  2004-08-17       Impact factor: 8.262

3.  Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.

Authors:  Panagiotis N Papanikolaou; Georgia D Christidi; John P A Ioannidis
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

Review 4.  Choosing between randomised and non-randomised studies: a systematic review.

Authors:  A Britton; M McKee; N Black; K McPherson; C Sanderson; C Bain
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

5.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.